CLINICAL_TRIALS
trial_result
· 2025-04-09
Clinical Trial Update: Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) [Phase 3]
Summary
Phase 3 randomized study of apremilast in Japanese participants with palmoplantar pustulosis has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Palmoplantar Pustulosis | Phase 3 | Status: COMPLETED | Results posted: 2025-04-09